FI980822A - Pharmaceutical composition on the skin or mucosal surface of the active substance or through the skin or mucosa surface - Google Patents

Pharmaceutical composition on the skin or mucosal surface of the active substance or through the skin or mucosa surface Download PDF

Info

Publication number
FI980822A
FI980822A FI980822A FI980822A FI980822A FI 980822 A FI980822 A FI 980822A FI 980822 A FI980822 A FI 980822A FI 980822 A FI980822 A FI 980822A FI 980822 A FI980822 A FI 980822A
Authority
FI
Finland
Prior art keywords
skin
pharmaceutical composition
active substance
mucosa
mucosal
Prior art date
Application number
FI980822A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI980822A0 (en
Inventor
Lise Sylvest Nielsen
Jens Hansen
Original Assignee
Gs Dev Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gs Dev Ab filed Critical Gs Dev Ab
Publication of FI980822A publication Critical patent/FI980822A/en
Publication of FI980822A0 publication Critical patent/FI980822A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI980822A 1995-10-12 1998-04-09 Pharmaceutical composition on the skin or mucosal surface of the active substance or through the skin or mucosa surface FI980822A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK115095 1995-10-12
PCT/DK1996/000437 WO1997013528A1 (en) 1995-10-12 1996-10-11 A pharmaceutical composition for administration of an active substance to or through a skin or mucosal surface

Publications (2)

Publication Number Publication Date
FI980822A true FI980822A (en) 1998-04-09
FI980822A0 FI980822A0 (en) 1998-04-09

Family

ID=8101575

Family Applications (1)

Application Number Title Priority Date Filing Date
FI980822A FI980822A0 (en) 1995-10-12 1998-04-09 Pharmaceutical composition on the skin or mucosal surface of the active substance or through the skin or mucosa surface

Country Status (7)

Country Link
EP (1) EP0871489A1 (en)
JP (1) JPH11513393A (en)
AU (1) AU702030B2 (en)
CA (1) CA2231273A1 (en)
FI (1) FI980822A0 (en)
NO (1) NO981633L (en)
WO (1) WO1997013528A1 (en)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6440980B1 (en) 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
US6458373B1 (en) 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
JP2001524958A (en) * 1997-04-17 2001-12-04 ジーエス ディベロップメント アクティエボラーグ A novel liquid crystal based bioadhesive drug delivery system
AU731909B2 (en) 1997-07-01 2001-04-05 Isis Pharmaceuticals, Inc. Compositions and methods for the delivery of oligonucleotides via the alimentary canal
EP1001747A1 (en) * 1997-08-09 2000-05-24 Smithkline Beecham Plc Compositions for nasal administration
IL129848A (en) * 1997-09-09 2003-04-10 Select Release L C Coated particles and methods of making and using same
SE9703458D0 (en) * 1997-09-25 1997-09-25 Pharmacia & Upjohn Ab Nicotine compositions and methods of formulation thereof
EP1469009A2 (en) * 1998-05-21 2004-10-20 Isis Parmaceuticals, Inc. Compositions and methods for non-parenteral delivery of oligonucleotides
US7030155B2 (en) 1998-06-05 2006-04-18 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
GB9827034D0 (en) * 1998-12-10 1999-02-03 Univ Manchester Delivery formulation
CN1368874A (en) * 1999-08-06 2002-09-11 马克斯－德尔布吕克分子医学研究所 Implantable active ingredient depot
EP1239923A2 (en) * 1999-12-20 2002-09-18 New Pharma Research Sweden AB Stabilized veterinary compositions comprising more than one antiviral agent
DE10057769A1 (en) 2000-11-22 2002-05-23 Beiersdorf Ag Use of a composition for cosmetic or dermatological hair care products, comprises dispersed liquid crystals forming a cubic phase as a base
SK287423B6 (en) * 2001-04-30 2010-09-07 Trommsdorff Gmbh & Co. Kg Arzneimittel Pharmaceutically active uridine esters, the use of them, method for the preparation of said uridine esters and pharmaceutical composition
US7439271B2 (en) * 2001-06-27 2008-10-21 The Gillette Company Reduction of hair growth
US20030124196A1 (en) 2001-08-22 2003-07-03 Susan Weinbach Pulsatile release compositions and methods for enhanced intestinal drug absorption
EP1667656A4 (en) * 2003-09-01 2011-12-28 Mayne Pharma Int Pty Ltd Compositions and methods for delivery of biologically active agents
US8236292B2 (en) 2004-06-04 2012-08-07 Camurus Ab Liquid depot formulations
EP1812022B1 (en) 2004-09-28 2014-01-15 Atrium Medical Corporation Stand-alone film and methods for making the same
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US9801982B2 (en) 2004-09-28 2017-10-31 Atrium Medical Corporation Implantable barrier device
EP1804717A4 (en) 2004-09-28 2015-11-18 Atrium Medical Corp Drug delivery coating for use with a stent
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US9649382B2 (en) 2005-01-14 2017-05-16 Camurus Ab Topical bioadhesive formulations
PL1848403T3 (en) * 2005-01-14 2010-09-30 Camurus Ab Topical bioadhesive formulations
US8920782B2 (en) 2005-01-14 2014-12-30 Camurus Ab Topical bioadhesive formulations
CA2594711C (en) * 2005-01-14 2012-11-06 Camurus Ab Somatostatin analogue formulations
US8871712B2 (en) 2005-01-14 2014-10-28 Camurus Ab Somatostatin analogue formulations
CA2595385C (en) 2005-01-21 2011-01-25 Camurus Ab Pharmaceutical lipid compositions
MX2007014068A (en) * 2005-05-10 2008-02-07 Novartis Ag Modified release famciclovir pharmaceutical compositions.
WO2006131730A1 (en) 2005-06-06 2006-12-14 Camurus Ab Glp-1 analogue formulations
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
US9278161B2 (en) 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
US8574627B2 (en) 2006-11-06 2013-11-05 Atrium Medical Corporation Coated surgical mesh
CA2626030A1 (en) 2005-10-15 2007-04-26 Atrium Medical Corporation Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings
DK2086504T3 (en) 2006-10-17 2014-04-07 Nuvo Res Inc Diclofenac Gel
US9492596B2 (en) 2006-11-06 2016-11-15 Atrium Medical Corporation Barrier layer with underlying medical device and one or more reinforcing support structures
GB0711656D0 (en) 2007-06-15 2007-07-25 Camurus Ab Formulations
GB0716385D0 (en) 2007-08-22 2007-10-03 Camurus Ab Formulations
JP5600101B2 (en) * 2008-06-09 2014-10-01 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Devices and methods for determining properties of aerosol formulations
GB0815435D0 (en) 2008-08-22 2008-10-01 Camurus Ab Formulations
US8546450B1 (en) 2009-03-31 2013-10-01 Nuvo Research Inc. Treatment of pain with topical diclofenac compounds
US8618164B2 (en) 2009-03-31 2013-12-31 Nuvo Research Inc. Treatment of pain with topical diclofenac compounds
EP2498754B1 (en) 2009-06-25 2018-06-06 Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd. Reverse hexagonal mesophases (h ii) and uses thereof
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
EP2593141B1 (en) 2010-07-16 2018-07-04 Atrium Medical Corporation Composition and methods for altering the rate of hydrolysis of cured oil-based materials
AU2013265210B2 (en) 2012-05-25 2016-09-15 Camurus Ab Somatostatin receptor agonist formulations
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery
EP2877155B1 (en) 2012-07-26 2020-10-28 Camurus AB Opioid formulations
AU2018255510B2 (en) 2017-04-20 2024-05-30 Zeenar Enterprises Pty Ltd Liquid crystalline dosage form for administering a statin
CN112770778A (en) * 2018-09-07 2021-05-07 法纳克斯株式会社 External preparation containing non-lamellar liquid crystal forming lipid
EP3870155A4 (en) * 2018-10-25 2023-08-09 Zeenar Enterprises Pty Ltd Composition that forms liquid crystalline particles
CN111821254B (en) * 2019-04-18 2021-10-15 华东师范大学 Antiviral hydrogel and preparation method and application thereof
CN111759858B (en) * 2020-06-02 2022-09-20 杭州英健生物科技有限公司 PH-sensitive digestive tract mucosa protective gel and application thereof
CN112791047A (en) * 2021-01-15 2021-05-14 中国人民解放军总医院第三医学中心 Resveratrol lamellar liquid crystal and preparation method thereof
EP4419884A2 (en) * 2021-10-19 2024-08-28 Sensach AB Lipid patch
WO2023189270A1 (en) * 2022-03-28 2023-10-05 富士フイルム株式会社 Biomaterial composition
WO2023189273A1 (en) * 2022-03-28 2023-10-05 富士フイルム株式会社 Biological composition
WO2024068672A1 (en) * 2022-09-26 2024-04-04 Universität Bern Structured lipid compositions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2631282A1 (en) * 1976-07-12 1978-01-19 Kali Chemie Pharma Gmbh Increasing solubility of pharmaceutical used e.g. in gelatin capsules - by dissolving in fatty acid mono:glyceride cpds. and then rapidly cooling
SE457933B (en) * 1987-07-06 1989-02-13 Larsson Kare PHARMACEUTICAL COMPOSITION INCLUDING A WATER DISPERSED MIXTURE OF LIPIDS, MONOGLYCERIDES AND PHOSPHATIDYLCOLINE AND ITS APPLICATION FOR THE PREPARATION OF A GASTRONIN TESTINALLY EFFECTIVE COMPOSITION
CA2038744C (en) * 1990-03-23 2002-01-08 Yoshitomi Pharmaceutical Industries Ltd. Pharmaceutical composition containing slightly water-soluble drug
WO1995026715A2 (en) * 1994-03-30 1995-10-12 Dumex-Alpharma A/S Use of fatty acid esters as bioadhesive substances

Also Published As

Publication number Publication date
EP0871489A1 (en) 1998-10-21
AU702030B2 (en) 1999-02-11
WO1997013528A1 (en) 1997-04-17
JPH11513393A (en) 1999-11-16
AU7279296A (en) 1997-04-30
CA2231273A1 (en) 1997-04-17
NO981633L (en) 1998-06-04
FI980822A0 (en) 1998-04-09
NO981633D0 (en) 1998-04-08

Similar Documents

Publication Publication Date Title
FI980822A0 (en) Pharmaceutical composition on the skin or mucosal surface of the active substance or through the skin or mucosa surface
DE69830095D1 (en) Pharmaceutical, cosmetic or dermo-pharmaceutical patch for the administration of several different active substances
BR9610153A (en) Pharmaceutical formulations
BR9611626A (en) Pharmaceutical formulations
NO962606L (en) Pharmaceutical composition
ID24654A (en) OMEPRAZOLA PHARMACEUTICAL FORMULATION
BR9607317A (en) Peptides and pharmaceutical composition
BR9607318A (en) Peptides and pharmaceutical composition
EE04390B1 (en) Topical preparation for the treatment of dermatological conditions
IS5665A (en) Pharmaceutical pressure spray composition
PT907364E (en) PHARMACEUTICAL COMPOSITION OF SUSTAINED LIBERTACAO
NO954486D0 (en) Pharmaceutical formulation basis
BR9610396A (en) Pharmaceutical formulation
IT1295645B1 (en) APPARATUS FOR THE ELECTRO-EMANATION OF ACTIVE INGREDIENTS.
EE04681B1 (en) 3,6-Half-Ketals of the 9a-Azalides, Method of Preparation and Pharmaceutical Composition
FI964619A0 (en) Dosage of antiepileptic drugs on the skin
LV11727A (en) Pharmaceutical composition
FI973229A0 (en) New pharmaceutical composition
BR9806083A (en) Pharmaceutical composition for the treatment of hapattite c
PT1017388E (en) Pharmaceutical composition containing IBUPROFEN AND DOMPERIDONE FOR THE TREATMENT OF ENXAQUECA
FI973280A (en) Pharmaceutical composition
TR199600583A2 (en) Increasing the tolerability of amino acids with pharmaceutical activity.
FI973230A (en) New pharmaceutical formulation
BR9606066A (en) Compound and pharmaceutical formulation
BR9605777A (en) Pharmaceutical composition